This site uses cookies, including third-party cookies, that help us to provide and improve our services. Read More

Carbapenem-based Antibiotics Market

Carbapenem-based Antibiotics Market

Carbapenem-based Antibiotics Market Size, Trend Analysis & Competition Tracking By Product Type (Meropenem, Ertapenem, Panipenem, Tebipenem), By Indication (Intra-abdominal Infections, Bacterial Meningitis, Skin and Skin Structure Infections, Acute Pelvic Infections) - Global Market Insights 2021 to 2031

Carbapenem-based Antibiotics Market
FACT4425MR
  • Mar-2022
  • List of Tables : 42
  • List of Figures : 110
  • 170 Pages
  • Healthcare

Carbapenem-based Antibiotics Market to Register Strong Growth, on Back of Increasing Incidence of Hospital Acquired Pneumonia and Bacterial Infections

Incidence of bacterial infections is increasing rapidly across the world offering significant revenue generating opportunities for the carbapenem-based antibiotics market. Pneumonia acquired in hospital settings due to longer patient stays, is often difficult to treat and exists as the comorbidity to various chronic diseases such as cancer, organ transplant. etc. It also interferes with the disease treatment and may be fatal if not treated with broad-spectrum antibiotics such as carbapenem-based antibiotics.

As per the Center for Disease Control (CDC), people admitted to hospital settings due to various reasons such as immunosuppressive treatment and inappropriately followed infection control protocol, suffer from hospital-acquired pneumonia (HAP). Along with HAP, incidence of various bacterial diseases is increasing rapidly, which in turn is expected to drive the growth of the carbapenem-based antibiotics market.

Carbapenem based antibiotics market by Fact.MR

Surgery-Associated Bacterial Infection to Boost Demand for Carbapenem-Based Antibiotics

Some forms of chronic diseases often require open surgery as a treatment protocol. Before performing open surgery, carbapenem-based antibiotics are often administered as the prophylactic measure for the prevention of surgery-related bacterial infections.

The World Health Organization also emphasizes on infection control protocol i.e. prophylactic administration of the carbapenem-based antibiotics that can limit or eliminate the chances of surgery-associated bacterial infection. As per WHO, 30% of global disease burden is accruing to surgery related diseases pointing towards a heightened demand for prophylactic, carbapenem-based antibiotics.

Carbapenem-based Antibiotics Market Gains Traction, with Generic Alternatives to Ertapenem to be Lucrative Revenue Pockets

Ertapenem is one of the most widely used carbapenem-based antibiotics and its patent expired in November 2017. Various regional as well as global pharmaceutical companies are assessing feasibility for possible re- launch of generic version of ertapenem in various regions.

For instance, in June 2018, Aurobindo Pharma received FDA approval for generic Invanz injection. Invanz is Merck Sharp and Dohme Corp.’s joint carbapenem-based antibiotic product for the treatment of various bacterial infections. The launch of various generic version of carbapenem-based antibiotics such as ertapenem in regions such as North America and Europe is expected to offer substantial revenue generation opportunities.

Lower price of generic carbapenem-based antibiotics is expected to result in increased product adoption, thus compelling carbapenem-based antibiotic manufacturers to enhance geographical footprint in lower- and middle-income countries. Increasing supply-chain operations in regions such as North America, East Asia and Europe will further give impetus to high revenue generating carbapenem-based antibiotics markets.

Carbapenem based antibiotics market 01 by Fact.MR

Competitive Landscape

  • Pfizer Inc.
  • Merck Co. & Inc.
  • Sumitomo Dainippon Pharma Co., Ltd.

are top players operating in the carbapenem-based antibiotics market. The top three players contributed more than 92% revenue share in the carbapenem-based antibiotics market in 2018.

Key players are prominently focusing on increasing their carbapenem-based antibiotics availability in different countries for the treatment of a large patient pool with bacterial infections.

Avail customized purchase options for your needs

Key Segments of Carbapenem-based Antibiotics Market

Fact.MR’s study on the carbapenem-based antibiotics therapy market offers information divided into four important segments - product, indication, sales channel, and region. This report offers comprehensive data and information about the important market dynamics, and growth parameters associated with these categories.

Product Type
  • Meropenem
  • Ertapenem
  • Imipenem
  • Doripenem
  • Panipenem
  • Tebipenem
Indication
  • Intra-abdominal Infections
  • Urinary Tract Infections
  • Pneumonia
  • Bacterial Meningitis
  • Skin and Skin Structure Infections
  • Acute Pelvic Infections
  • Prophylaxis of Surgical Site Infection
  • Respiratory Tract Infections
  • Gynaecologic Infections
  • Endocarditis
  • Others
Sales Channel
  • Hospital Pharmacies
  • Retail Pharmacies & Drug Stores
  • Online Pharmacies
Region
  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

- FAQs -

In June 2018, Aurobindo Pharma received FDA approval for generic Invanz injection.
Meropenem,Ertapenem,Doripenem,Panipenem,Tebipenem are the product types of Carbapenem-based Antibiotics Market.

Need an Exclusive Report for your Unique Requirement?

- Related Reports -

Patient Temperature Management Systems Market

Patient temperature management systems market is anticipated to record nearly US$ 2,860 Million and ...

Geriatric Medicines Market

Geriatric Medicines Market expects a 7% CAGR growth during 2021-2031. Analgesic geriatric medicines ...

Antibacterial Washcloth Market

Antibacterial Washcloth Market research report covers detailed information on Global Antibacterial W...

Endoscopic Balloon Dilator Market

Endoscopic Balloon Dilator Market research report segmented By product type (Biliary balloon dilator...

- Our Clients -

Report Client

- Evaluate How Fact.MR's Report Can Help. -

Is the market research conducted by Fact.MR?

Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.

What research methodology is followed by Fact.MR?

Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.

What are the sources of secondary research?

Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.

Who are the respondents for primary research?

Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.

Is a sample of this report available for evaluation?

Yes, you can request a sample, and it will be sent to you through an email.